House Ethics Panel Was Set to Vote to Release Report Critical of Matt Gaetz
The committee has been investigating allegations that Mr. Gaetz, President-elect Donald J. Trump’s pick for attorney general, ...
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...
Johnson Says He Will Object to Release of Ethics Report on Gaetz
The House speaker said revealing the findings of a yearslong inquiry into allegations of sexual misconduct and drug use would ...
Cure Today15h
FDA Approves Danziten for Leukemia Subset That Does Not Require Fasting
Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...
FierceBiotech3d
FDA hits Kezar's zetomipzomib program with 2nd clinical hold in 2 months
The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...
dvm3603d
FDA approves renewal for canine chemotherapy-induced diarrhea treatment
Jaguar Health announced that its product, cofelemer delayed-release tablets (Canalevia-CA1; Jaguar Health), received approved ...
Check your cinnamon before baking a pie. FDA recalls cinnamon in CT due to high lead levels
Before you add some cinnamon to your holiday baked goods, you should check to see if your cinnamon has been recalled. The ...
EurekAlert!4d
New lignin-based hydrogel breakthrough for wound healing and controlled drug release
This study introduces a novel lignin-based hydrogel with controlled release and enhanced mechanical strength, leveraging ...
Crain's Chicago Business1d
UChicago to harness Argonne's AI, supercomputer tools for cancer drug discovery
With a federal grant in hand, researchers at the health system and national lab will try to hit fast forward on the long and ...
FiercePharma3d
FDA rejects Intercept's ask for Ocaliva full nod in rare liver disease, but accelerated approval remains
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
FDA approves Emrosi for rosacea in adults
The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...
Pressure Increases for House to Release Matt Gaetz Ethics Report
Trump's AG nominee resigned from Congress days before the committee was set to release the findings of its probe into ...